2Department of Neurology, University Hospital Basel, Basel, Basel-Stadt, Switzerland
3Department of Health Sciences, University of Genova, Genova, Italy
4Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Clinical Neurology, University of Genoa, Genoa, Liguria, Italy
5Department of Pediatric Neurology and Developmental Medicine, University Children’s Hospital Basel (UKBB), Switzerland
6Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, Netherlands
7Institute of Neuroscience and Medicine (INM-1), Forschungszentrum Jülich, Jülich, North Rhine-Westphalia, Germany
8Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Basel-Stadt, Switzerland
9Department of Biomedicine, University of Basel, Basel, Basel-Stadt, Switzerland
Presenting Author: Dimitrios G Gkotsoulias
Synopsis
Motivation:
Goals:
Approach:
Results:
Preview figure
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public on 13 May 2028.
To request or purchase access, contact the ISMRM Central Office at support@ismrm.org.
1. Lubetzki, C., Zalc, B., Williams, A., Stadelmann, C. & Stankoff, B. Remyelination in multiple sclerosis: from basic science to clinical translation. The Lancet Neurology 19, 678–688 (2020). 10.1016/S1474-4422(20)30140-X. [doi]
2. Patrikios, P. et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129, 3165–3172 (2006). 10.1093/brain/awl217. [doi]
3. Strijbis, E. M. M., Kooi, E.-J., van der Valk, P. & Geurts, J. J. G. Cortical Remyelination Is Heterogeneous in Multiple Sclerosis. J Neuropathol Exp Neurol 76, 390–401 (2017). 10.1093/jnen/nlx023. [doi]
4. Rahmanzadeh, R. et al. A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis. Ann Neurol 92, 486–502 (2022). 10.1002/ana.26441. [doi]
5. Li, W., Wu, B. & Liu, C. Quantitative Susceptibility Mapping of Human Brain Reflects Spatial Variation in Tissue Composition. Neuroimage 55, 1645–1656 (2011). 10.1016/j.neuroimage.2010.11.088. [doi]
6. Liu, T., Xu, W., Spincemaille, P., Avestimehr, A. S. & Wang, Y. Accuracy of the Morphology Enabled Dipole Inversion (MEDI) Algorithm for Quantitative Susceptibility Mapping in MRI. IEEE Trans Med Imaging 31, 816–824 (2012). 10.1002/mrm.22816. [doi]
7. La Rosa, F. et al. Multiple sclerosis cortical and WM lesion segmentation at 3T MRI: a deep learning method based on FLAIR and MP2RAGE. Neuroimage Clin 27, 102335 (2020). 10.1016/j.nicl.2020.102335. [doi]
8. Fischl, B. FreeSurfer. Neuroimage 62, 774–781 (2012). 10.1016/j.neuroimage.2012.01.021. [doi]
9. Filippi, M. et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain 142, 1858–1875 (2019). 10.1093/brain/awz144. [doi]
10. Bergner, C. G. et al. BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis. Brain 148, 908–920 (2024). 10.1093/brain/awae293. [doi]
11. Brown, J. W. L. et al. Remyelination varies between and within lesions in multiple sclerosis following bexarotene. Ann Clin Transl Neurol 9, 1626–1642 (2022). 10.1002/acn3.51662. [doi]
12. Galloway, D. A., Gowing, E., Setayeshgar, S. & Kothary, R. Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination. Glia 68, 859–877 (2020). 10.1002/glia.23711. [doi]
13. Tonietto, M. et al. Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration. Brain 146, 182–194 (2023). 10.1093/brain/awac334. [doi]